Corpora Amylacea in Neurodegenerative and Aging Brain

Corpora amylacea are spherical, polyglucosan-rich inclusions that accumulate in the human brain during normal ageing and in a variety of neurodegenerative disorders. Originally observed at the light-microscopic level, these bodies have been shown by ultrastructural and proteomic studies to comprise dense networks of lipid membranes, preserved organelles and entrapped waste products. Rather than inert deposits, they appear to serve as dynamic waste containers that sequester damaged proteins, organelles and, in some cases, microbial components. Their distribution is regionally specific—often perivascular, subpial or periventricular—and their abundance correlates with age and the severity of underlying pathology. Emerging evidence highlights their interaction with natural IgM antibodies, their potential release into cerebrospinal fluid and their ultimate clearance via glymphatic and immune pathways. As such, corpora amylacea are gaining traction as both indicators of brain health and possible therapeutic targets in conditions such as Alzheimer’s disease, frontotemporal lobar degeneration and vascular insults.

Research from Nature Portfolio

Foundational ultrastructural analyses have revealed that corpora amylacea consist of tightly packed membranous labyrinths containing intact mitochondria and vesicular elements, primarily within perivascular glial cells. Complementary proteomic investigations of inclusions purified from Alzheimer’s cortex demonstrated a complex repertoire of human proteins alongside microbial peptides, suggesting a role in scavenging debris derived from infections. In parallel, high-resolution studies of hippocampal specimens defined the formation of immature, debris-filled bodies within astrocytic processes that mature into highly fibrillar, compact structures. These works collectively reinforce the view of corpora amylacea as active participants in waste sequestration and innate immune recognition.

Corpora Amylacea in Neurodegenerative and Aging Brain publication trend

The graph below shows the total number of articles in corpora amylacea in neurodegenerative and aging brain across all publications each year (not limited to Nature Index journals).

Technical terms

Polyglucosan body: Intracellular aggregate of glucose polymers forming the core of corpora amylacea.

Wasteosome: Alternative term for corpora amylacea emphasising their role as waste-containing structures.

Neo-epitope: Novel antigenic determinant generated during degeneration and recognised by natural IgM antibodies.

Glymphatic system: Brain clearance pathway involving fluid flow along perivascular spaces and facilitated by glial cells.

Opsonisation: Tagging of particles by complement or lectins to promote phagocytic uptake.

References

1. New perspectives on corpora amylacea in the human brain. Scientific Reports (2017).
2. Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles. Scientific Reports (2018).
3. Human and Microbial Proteins From Corpora Amylacea of Alzheimer’s Disease. Scientific Reports (2018).
4. Astrocytes are involved in the formation of corpora amylacea-like structures from neuronal debris in the CA1 region of the rat hippocampus after ischemia. Frontiers in Cellular Neuroscience (2023).
5. Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology. Acta Neuropathologica Communications (2024).
6. Uncovering tau in wasteosomes (corpora amylacea) of Alzheimer’s disease patients. Frontiers in Aging Neuroscience (2023).
7. Neo-epitopes emerging in the degenerative hippocampal granules of aged mice can be recognized by natural IgM auto-antibodies. Immunity & Ageing (2015).
8. Wasteosomes (corpora amylacea) of human brain can be phagocytosed and digested by macrophages. Cell & Bioscience (2022).